MDMA (Ecstacy): Useful information for health professionals involved in drug education programs

Journal of Drug Education

Volumn 26, Issue 4, 1996, Pages 349-356

  Elk, Carrie ^a,b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; CENTRAL STIMULANT AGENT; LYSERGIDE; MESCALINE; PSYCHEDELIC AGENT;

AGITATION; ARTICLE; CARDIOTOXICITY; DEPRESSION; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; DRUG DEPENDENCE; DRUG FORMULATION; DRUG INFORMATION; DRUG OVERDOSE; DRUG RESEARCH; EDUCATION PROGRAM; HALLUCINATION; HUMAN; INSOMNIA; KIDNEY FAILURE; NEUROTOXICITY; PSYCHOSIS; VOMITING;

EID: 0030485117     PISSN: 00472379     EISSN: None     Source Type: Journal    
DOI: 10.2190/K2PL-Q2YF-WNG0-54QD     Document Type: Article

References (14)

1. S. Redhead (ed.), Rave Off Politics and Deviance in Contemporary Youth Culture, Avebury, 1993.
2. M. A. Schuckit, MDMA (Ecstasy): An Old Drug with New Tricks, Drug Abuse & Alcoholism Newsletter, XXIII-2, April 1994.
3. R. P. Climko, H. Roehrich, D. R. Sweeney, and J. Al-Razi, Ecstacy: A Review of MDMA and MDA, International Journal of Psychiatry in Medicine, 16:4, pp. 359-372, 1986-1987.
4. N. Solowij, W. Hall, and N. Lee, Recreational MDMA Use in Sydney: A Profile of "Ecstasy" Users and Their Experiences with the Drug, British Journal of Addiction, 87, pp. 1161-1172, 1992.
5. J. Beck, MDMA: The Popularization and Resultant Implications of a Recently Controlled Psychoactive Substance, Contemporary Drug Problems, pp. 23-61, 1986.
6. P. Glanzrock, Ecstasy a Dose of Generation X, Psychology Today, pp. 16-17, May/June 1994.
7. D. M. Barnes, Ecstasy Returns to Schedule I, Science, 240(4848):24, April 1, 1988.
8. G. N. Hayner and H. McKinney, MDMA The Dark Side of Ecstasy, Journal of Psychoactive Drugs, 18:4, October-December 1986.
9. L. H. Price, G. A. Ricaurte, J. H. Krystal, and G. R. Heninger, Neuroendocrine and Mood Responses to Intravenous L-Tryptophan in 3,4-Methylenedioxymethamphetamine (MDMA) Users, Archives of General Psychiatry, 46, January 1989.
10. U.S. Department of Health and Human Services, Document Number 285071270, September 1989.
11. M. D. Schechter, Serotonergic-Dopaminergic Mediation of 3,4-Methylenedioxy-methamphetamine (MDMA, "Ecstasy"), Pharmacology Biochemistry & Behavior, 31, pp. 817-824, 1989.
12. M. D. Schechter, Effect of MDMA Neurotoxicity Upon Its Conditioned Place Preference and Discrimination, Pharmacology Biochemistry & Behavior, 33, pp. 539-544, 1991.
13. S. J. Peroutka, 'Ecstasy': A Human Neurotoxin? Letters to the Editor, Archives of General Psychiatry, 46, February 1989.
14. Article Netnews, Newsgroup: alt. drugs. Subject Re:XTC, 460:1, September 3, 1994.